INTRODUCTION
Staphylococcus aureus causes various diseases in primates and non-primates. Administration of several potent antibiotics (such as methicillin, oxacillin, rifampin, ciprofloxacin and tetracyclines) since 1940s has not brought the S. aureus-mediated infections under control primarily because of the emergence and dissemination of multiple antibiotic-resistant S. aureus strains and the non-availability of an effective vaccine (1, 2) . The glycopeptide antibiotics, once found to be very effective against multi drug-resistant strains, could not be administered for long as S. aureus strains with resistance to vancomycin and the related antibiotics have emerged across the world lately (3) . To date, staphylococcal resistances to linezolid, daptomycin and tigecycline are low but these compounds have some serious limitations (4) . Recently, a few new compounds (e.g., ceftobiprole, telavancin, iclaprim, etc.) have been discovered that exhibit promising activity against most bacteria including S. aureus (4) . As the new inhibitors are at various phases of development, additional antistaphylococcal compounds need to be screened or developed on a priority basis.
The drp35 gene of Staphylococcus aureus encodes a cytoplasmic protein that possesses calcium-dependent lactonase activity (5, 6) . Interestingly, drp35 was induced by various cell wall-affecting antibiotics (such as β-lactams, bacitracin, fosfomycin and vancomycin) as well as by detergents that damage cell membrane (5, 7) . Transcription from drp35 promoter though seems to be induced by cell wall inhibitors has not been cloned and characterized yet.
Several recombinant bacterial strains have been constructed by fusing antibiotic-inducible promoters to reporter genes (for example, lacZ, lux, etc.) in the last two decades (8) (9) (10) (11) (12) (13) (14) (15) (16) . Biological assay systems, developed with the above reporter strains, were suggested to be useful for screening novel compounds capable of inhibiting various macromolecular biosyntheses including cell wall biosynthesis. Bacterial enzymes involved in cell wall biosynthesis are considered attractive targets of drug discovery (17) . Only a few Staphylococcus aureus reporter strains (14) have been constructed for screening cell wall-affecting compounds and the drp35 promoter is yet to be utilized for this purpose. In this communication, we have reported the cloning of the drp35 promoter from Staphylococcus aureus Newman and demonstrated its induction specifically by cell wall-affecting antibiotics. Our data also suggest that a 96-well microplate assay, developed with an engineered Staphylococcus aureus strain SAU1289 (harboring a chromosomally-integrated drp35 promoter -lacZ transcriptional fusion), would be suitable for screening new cell wall inhibitors efficiently. http://bmbreports.org BMB reports Estimation of β-galactosidase levels in SAU1288 under different conditions. SAU1288 cells were grown in nutrient broth (containing chloramphenicol) to log phase. Culture aliquots were exposed separately to 0.5 MIC equivalents of ampicillin (Amp), cefalothin (Cef) and kanamycin (Kan) for 30 min followed by the estimation of β-galactosidase levels in all aliquots by a standard method (19) 
RESULTS AND DISCUSSION

Cloning of the promoter of S. aureus drp35
The region immediately preceding the coding region of drp35 might harbor its promoter (designated Pd) as Staphylococcus aureus carries drp35 gene and its upstream gene in the divergent orientation (5) . To confirm the above hypothesis, we generated a plasmid, p1288 (Fig. 1A) , by cloning the putative Pd carrying region at the upstream of promoterless lacZ gene (encoding β-galactosidase) in p1287 (see Materials and Methods for details). SAU1287 and SAU1288 strains, constructed by transforming S. aureus RN4220 with p1287 and p1288, respectively, were grown on trypticase soy agar supplemented with MUG (4-methylumbelliferyl-β-D-galactopyranoside). The cell colonies if express β-galactosidase from the resident plasmid would generate 4-methylumbelliferone from MUG (18) . As 4-methylumbelliferone fluoresces in the presence of UV light, colonies synthesizing this compound would appear as fluorescent colonies under UV light. Upon exposure to UV light, colonies of SAU1288 were indeed fluorescent, whereas, SAU1287 colonies did not fluoresce under identical conditions (Fig. 1B) , indicating the presence of a promoter at the upstream of the drp35 coding region.
Cell wall-affecting antibiotics induce Pd
To see whether Pd in SAU1288 retained the antibiotic-in-http://bmbreports.org (B) Agarose-based assay in the presence of multiple antibiotics. Assay was performed as described above except that 4 to 5 antibiotics (indicated) were added together to a paper disc. Five hundred nanogram of rifampicin or cefalothin along with 1 μg each of the other antibiotics were added to the paper disc. Abbreviations used for antibiotics are the same as described above. (C) Estimation of β-galactosidase levels in SAU1289. The β-galactosidase level in each of the indicated antibiotic-treated SAU1289 culture aliquots was determined by a standard method (19) using ONPG (o-nitrophenyl-β-D-galactopyranoside) as the enzyme substrate. 'Con' indicates β-galactosidase level in the antibiotic-untreated SAU1289 culture aliquot. Fold induction was measured by dividing the β-galactosidase level in the antibiotic-treated culture with the β-galactosidase level in the control culture. The error bars indicate standard deviations (n≥2).
ducible property, we exposed SAU1288 culture aliquots to subinhibitory concentrations of ampicillin, cefalothin, and kanamycin, separately, for 30 min followed by measuring β-galactosidase levels in the aliquots as described by Miller (19) . The levels of β-galactosidase in the ampicillin-and cefalothin-treated aliquots were found about ~5-6 fold higher than those in the kanamycin-treated or antibiotic-untreated cultures (all P values are ＜ 0.006; Fig. 1C ), indicating that Pd is induced by ampicilin and cefalothin but not by kanamycin.
Construction of a recombinant S. aureus strain harboring single copy Pd-lacZ transcriptional fusion
To study the effects of different antibiotics on drp35 promoter more precisely, a recombinant S. aureus strain (designated SAU1289; Fig. 1D ) was constructed by transforming p1289 (see Materials and Methods for details) to S. aureus RN4220 (Fig. 1E ) according to the standard procedure (16) . The Pd-lacZ transcriptional fusion in p1289 was expected to be integrated into the RN4220 chromosome as this plasmid lacks an S. aureus-specific origin of replication. To determine whether PdlacZ cassette was integrated into the drp35 locus by homologous recombination, a comparative analysis was made among the PCR-generated DNA fragments from SAU1289 and RN 4220 chromosomal DNAs using primer pairs P1 & P2, P1 & P4, P3 & P2, and P3 & P4. As shown in Fig. 1F , ~800 bp (lane 1) and ~ 620 bp (lane 5) DNA fragments were amplified from SAU1289 DNA using P3 & P4 and P1 & P4, respectively, whereas no PCR product was produced from RN4220 DNA by the same primer pairs. In contrast, DNA fragments of equal sizes were generated from both SAU1289 and RN4220 DNAs by the other primer pairs (lanes 2, 3, 6, and 8). Amplification of the above types of DNA fragments from SAU1289 and RN4220 indicates that former strain carries lacZ at the downstream of the drp35 promoter. Additional studies revealed that SAU1289 grows similarly to RN4220 and stably maintains the Pd -lacZ cassette in the absence of tetracycline (data not shown). SAU1289 also formed blue colonies on trypticase soy agar supplemented with X-Gal and exhibited induced expression of β-galactosidase in the presence of ampicillin (data not shown).
Development of an agarose-based assay with SAU1289
To demonstrate the antibiotic-mediated induction of Pd directly, we developed an agarose-based assay with SAU1289 and MUG according to a standard procedure (see Materials and Methods for details). Under the assay conditions, SAU1289 cells immediately around the zone of inhibition will appear as a 'fluorescent ring' if inhibitory antibiotic induces β-galactosidase expression. In SAU1289 background, fluorescent rings were indeed observed around the zones of inhibition formed by ciprofloxacin, rifampicin, ampicillin, vancomycin, bacitracin, and cefalothin ( Fig. 2A) . In contrast, no prominent fluorescent rings were detected around the zones of inhibition produced by trimethoprim and chloramphenicol. Erythromycin, http://bmbreports.org BMB reports tetracycline, and kanamycin also did not induce Pd (data not shown). The data together suggest that the above agarosebased assay involving SAU1289 and MUG may be useful for screening new antistaphylococcal agents including cell wall-affecting antibiotics, quinolones and rifampicin. Additional agarose-based assay indeed revealed that cefalothin or rifampicin, when mixed with tetracycline, kanamycin, trimethoprim and chloramphenicol, can also induce the formation of similar fluorescent rings by SAU1289 (Fig. 2B) .
Sublethal concentrations of cell wall-affecting antibiotics induce Pd
Induction of Pd by rifampicin and ciprofloxacin (as described above) was quite surprising as previous workers noticed the induction of drp35 only with cell wall-affecting antibiotics (7). This might have happened due to the longer exposure of the SAU1289 cells to the lethal concentrations of antibiotics in the agarose-based assay. To confirm the above hypothesis, we exposed aliquots of a nutrient broth-grown SAU1289 culture to 0.5 MIC equivalents of eleven representative antibiotics (mentioned above) separately, for 30 min followed by the estimation of the β-galactosidase levels in all aliquots according to Miller (19) . The β-galactosidase levels in the ampicillin, cefalothin, vancomycin and bacitracin-treated cells were found to be ~2-5 fold higher than those in the rifampicin, ciprofloxacin, and trimethoprim-treated cells or in cells grown in the absence of any antibiotic (all P values are ＜ 0.025; Fig. 2C ). Exposure of protein synthesis inhibitors also did not induce β-galactosidase expression in the liquid medium-grown SAU1289 cells. The data together indicate that cell wall-affecting antibiotics specifically induce the drp35 promoter.
Development of a microtiter plate assay with SAU1289
To determine whether SAU1289 could be employed in the large scale screening of antistaphylococcal compounds, we developed a microtiter plate-based assay according to a standard procedure (see Materials and Methods for details) using 100 μl SAU1289 cell aliquots and MUG as substrate. As shown in Fig. 3 , β-galactosidase levels in SAU1289 cells were increased about 5-9 fold when the cells were exposed to 0.25 MIC equivalents of ampicillin, cefalothin, vancomycin or bacitracin (all P values are ＜ 0.0003). Reporter enzyme levels were enhanced gradually in the presence of higher MICs of most cell wall-affecting antibiotics. Levels of β-galactosidase became nearly static at antibiotic concentrations greater than 1 MIC for all antibiotics. Contrary to the above, sublethal concentrations of rifampicin, chloramphenicol, erythromycin, and ciprofloxacin only marginally induced Pd in the microtiter plate format. The data together suggest that the above microtiter plate assay could be potentially used for the high-throughput screening of new cell wall-affecting compounds if the concentrations of these agents in the compound library are equivalent to 0.25 MIC and higher. Despite this restriction, strain SAU1289 appears to be more sensitive than the previously reported S. aureus reporter strains (14) constructed for similar purpose.
MATERIALS AND METHODS
Bacterial strains and plasmids
Most plasmids and bacterial strains used here were reported previously (13) . All S. aureus strains were grown in trypticase soy broth or nutrient broth. Escherichia coli DH5α was grown in Luria-Bertani broth. Antibiotics were added to growth media whenever needed. Minimum inhibitory concentrations (MICs) of different antibiotics for RN4220 were measured by a standard method (13).
Molecular biological techniques
All basic molecular biological techniques such as plasmid isolation, restriction enzyme digestion, agarose gel electerophoresis, DNA ligation, competent E. coli cell preparation, plasmid DNA transformation, polymerase chain reaction (PCR), chromosomal DNA isolation from S. aureus, electroporation of plasmids to S. aureus, etc. were performed using the standard http://bmbreports.org procedures (13, 20, 21) .
Construction of plasmids and strains
The putative drp35 promoter region was amplified by Pfu polymerase (Qiagen, Germany) using S. aureus Newman chromosomal DNA as the template and primers P1 (5'CTGCAGTT GATAGTTCATAGG) and P2 (5'GGATCCGATCAAAGTTCAA TCC). The resulting 409 bp DNA fragment was cloned into a T vector (Genei, India) after treatment with Taq polymerase and dATP (20) . One of the recombinant T vectors, carrying no mutations in the cloned DNA insert, was selected and named p1284. The 409 bp BamHI-PstI DNA fragment from p1284 that carries the putative drp35 promoter was subcloned into p1287 [a pLI50 (22) derivative harboring the promoterless lacZ gene from pAZ106 (23)] to generate p1288 (Fig. 1A) . S. aureus SAU1287 and SAU1288 were generated by transforming p1287 and p1288 to S. aureus RN4220 separately. The plasmid p1289 was generated by subcloning the 409 bp BamHI-PstI DNA fragment of p1284 into the identical sites of p1251 (13) . Using p1289, a S. aureus RN4220 derivative (designated SAU1289; Fig. 1C ) was constructed according to Chanda et al. (13) . The insertion of the Pd-lacZ transcriptional fusion into the SAU1289 chromosome was confirmed by PCR using primers P1, P2, P3 (5'CATCGGCATGCAT ATGTG) and P4 (5'TCGCTATTACGCCAGCTG). Based on the sequence of NWMN_2586 gene (annotated as drp35) of S. aureus Newman (NCBI, USA) and its upstream region, the oligonucleotides P1, P2, and P3 were designed. P4 was designed based on the N-terminal end sequence of the E. coli (http://genolist. pasteur.fr/colibri) lacZ gene.
Agarose-based assay
Agarose-based assay was performed according to Chanda et al. (13) . Briefly, a mixture of nutrient broth-grown SAU1289 cell culture and molten top agarose (nutrient broth medium + 0.6% agarose) was poured onto nutrient broth hard agarose. Sterile paper disks (diameter 0.5 cm) were placed on the solidified top agarose and soaked with an appropriate volume of antibiotic solution. The disks were removed after 16-18 h incubation of the plate at 37 o C followed by flooding the plate with a solution containing molten agarose and MUG. After 30 min incubation in the dark at 25 o C, plates were exposed to the long wave-length UV light and photographed.
ONPG assay
To study the effects of antibiotics on the β-galactosidase expression in SAU1288 or SAU1289, nutrient broth-grown cultures (OD590 ≈ 0.6) were divided into several 5 ml aliquots. One aliquot was grown continuously in the absence of antibiotic at 37 o C, whereas, each of the remaining aliquots were grown in the presence of 0.5 MIC of a specific antibiotic at the same temperature. After 30 min of growth, β-galactosidase levels in all culture aliquots were determined by a standard procedure (19) using ONPG (o-nitrophenyl-β-D-galactopyranoside) as the substrate.
Microtiter plate assay
Using MUG as the substrate, the β-galactosidase levels in a 96-well (black) microtiter plate-grown SAU1289 cell cultures were determined according to a standard procedure (13) . Briefly, 100 μl aliquots of nutrient broth-grown SAU1289 culture (OD620 ≈ 0.5) were added to wells containing an appropriate amount of antibiotic. After 3 h growth at 37 o C, 5 μl of 0.1% MUG solution was added to each well and the plate was incubated in the dark for an hour. Using a fluorescence plate reader (PolarStar Optima, BMG LabTechnologies, Germany), the fluorescence intensity in each well was measured at 460 nm after excitation at 355 nm. Immediately, culture was pulled out from each well followed by the determination of its optical density at 620 nm. Similarly, fluorescence intensity and the optical density of SAU1289 cells grown in the absence of antibiotic were measured. Fluorescence of growth medium and MUG were deducted from the fluorescence values recorded above. Using the fluorescence values of different concentrations of 4-Methyl umbelliferone, the concentration of hydrolyzed MUG (catalyzed by SAU1285) as well as the specific activity of β-galactosidase in each well was determined as previously reported (16) .
Statistical analysis
The β-galactosidase enzyme levels determined from the ONPG or microplate assay were analyzed by MS Excel using a paired Student's t test. The P values less than 0.05 were considered significant.
